O	0	10	Randomized
O	11	21	controlled
O	22	27	trial
O	28	30	of
B-intervention	31	40	cognitive
I-intervention	41	51	behavioral
I-intervention	52	58	stress
I-intervention	59	69	management
O	70	72	in
O	73	79	breast
O	80	86	cancer
O	86	87	:
O	88	89	a
O	90	95	brief
O	96	102	report
O	103	105	of
O	106	113	effects
O	114	116	on
O	117	118	5
O	118	119	-
O	119	123	year
O	124	134	depressive
O	135	143	symptoms
O	143	144	.

O	145	154	Survivors
O	155	157	of
O	158	164	breast
O	165	171	cancer
O	172	182	experience
O	183	189	stress
O	190	193	and
O	194	197	are
O	198	200	at
O	201	205	risk
O	206	209	for
O	210	220	depressive
O	221	229	symptoms
O	230	239	following
O	240	247	primary
O	248	257	treatment
O	257	258	.

O	259	264	Group
O	264	265	-
O	265	270	based
O	271	284	interventions
O	285	289	such
O	290	292	as
O	293	302	cognitive
O	302	303	-
O	303	313	behavioral
O	314	320	stress
O	321	331	management
O	332	333	(
O	333	337	CBSM
O	337	338	)
O	339	348	delivered
O	349	360	postsurgery
O	361	364	for
O	365	378	nonmetastatic
O	379	385	breast
O	386	392	cancer
O	393	394	(
O	394	397	BCa
O	397	398	)
O	399	403	were
O	404	414	previously
O	415	425	associated
O	426	430	with
O	431	436	fewer
O	437	447	depressive
O	448	456	symptoms
O	457	461	over
O	462	463	a
O	464	466	12
O	466	467	-
O	467	472	month
O	473	479	follow
O	479	480	-
O	480	482	up
O	482	483	;
O	484	487	few
O	488	495	studies
O	496	500	have
O	501	509	examined
O	510	513	the
O	514	520	longer
O	520	521	-
O	521	525	term
O	526	534	benefits
O	535	537	of
O	538	542	such
O	543	555	psychosocial
O	556	569	interventions
O	569	570	.

O	571	575	This
O	576	577	5
O	577	578	-
O	578	582	year
O	583	589	follow
O	589	590	-
O	590	592	up
O	593	598	study
O	599	601	of
O	602	603	a
O	604	614	previously
O	615	624	conducted
O	625	630	trial
O	631	632	(
O	632	633	#
O	633	644	NCT01422551
O	644	645	)
O	646	652	tested
O	653	660	whether
O	661	666	group
O	666	667	-
O	667	672	based
O	673	677	CBSM
O	678	687	following
O	688	695	surgery
O	696	699	for
O	700	713	nonmetastatic
O	714	717	BCa
O	718	721	was
O	722	732	associated
O	733	737	with
O	738	743	fewer
O	744	754	depressive
O	755	763	symptoms
O	763	764	.

O	765	770	Women
O	771	772	(
O	772	773	N
O	774	775	=
B-total-participants	776	779	240
O	779	780	)
B-eligibility	781	785	with
I-eligibility	786	791	Stage
I-eligibility	792	793	0
I-eligibility	793	794	-
I-eligibility	794	798	IIIb
I-eligibility	799	802	BCa
O	803	807	were
O	808	817	recruited
O	818	819	2
O	819	820	-
O	820	822	10
O	823	828	weeks
O	829	840	postsurgery
O	841	844	and
O	845	855	randomized
O	856	858	to
O	859	860	a
O	861	863	10
O	863	864	-
O	864	868	week
O	869	873	CBSM
O	874	886	intervention
O	887	892	group
O	893	895	or
O	896	897	a
B-control	898	899	1
I-control	899	900	-
I-control	900	903	day
I-control	904	910	psycho
I-control	910	911	-
I-control	911	922	educational
I-control	923	930	control
I-control	931	936	group
O	936	937	.

O	938	943	Women
O	944	948	were
O	949	960	recontacted
O	961	962	5
O	963	968	years
O	969	978	poststudy
O	979	989	enrollment
O	990	993	and
O	994	1005	reconsented
O	1006	1008	to
O	1009	1020	participate
O	1021	1023	in
O	1024	1027	the
O	1028	1034	follow
O	1034	1035	-
O	1035	1037	up
O	1038	1043	study
O	1044	1045	(
O	1045	1046	N
O	1047	1048	=
B-total-participants	1049	1052	130
O	1052	1053	)
O	1053	1054	.

O	1055	1065	Depressive
O	1066	1080	symptomatology
O	1081	1084	was
O	1085	1093	assessed
O	1094	1099	using
O	1100	1103	the
O	1104	1110	Center
O	1111	1114	for
O	1115	1128	Epidemiologic
O	1129	1136	Studies
O	1136	1137	-
O	1137	1147	Depression
O	1148	1153	scale
O	1154	1155	(
O	1155	1158	CES
O	1158	1159	-
O	1159	1160	D
O	1160	1161	)
O	1161	1162	.

O	1163	1168	ANOVA
O	1169	1172	and
O	1173	1179	ANCOVA
O	1180	1188	analyses
O	1189	1193	were
O	1194	1202	employed
O	1203	1205	to
O	1206	1210	test
O	1211	1214	for
O	1215	1220	group
O	1221	1232	differences
O	1233	1235	on
O	1236	1239	the
O	1240	1243	CES
O	1243	1244	-
O	1244	1245	D
O	1246	1248	at
O	1249	1250	5
O	1250	1251	-
O	1251	1255	year
O	1256	1262	follow
O	1262	1263	-
O	1263	1265	up
O	1266	1276	accounting
O	1277	1280	for
O	1281	1289	relevant
O	1290	1300	covariates
O	1300	1301	.

O	1302	1314	Participants
O	1315	1323	assigned
O	1324	1326	to
O	1327	1331	CBSM
O	1332	1340	reported
O	1341	1354	significantly
O	1355	1360	fewer
B-outcome	1361	1371	depressive
I-outcome	1372	1380	symptoms
O	1381	1382	(
O	1382	1383	M
O	1384	1385	=
B-iv-cont-mean	1386	1387	9
I-iv-cont-mean	1387	1388	.
I-iv-cont-mean	1388	1390	99
O	1390	1391	,
O	1392	1394	SE
O	1395	1396	=
B-iv-cont-sd	1397	1398	0
I-iv-cont-sd	1398	1399	.
I-iv-cont-sd	1399	1401	93
O	1401	1402	)
O	1403	1405	at
O	1406	1409	the
O	1410	1416	follow
O	1416	1417	-
O	1417	1419	up
O	1420	1428	compared
O	1429	1433	with
O	1434	1439	those
O	1440	1442	in
O	1443	1446	the
O	1447	1454	control
O	1455	1460	group
O	1461	1462	(
O	1462	1463	M
O	1464	1465	=
B-cv-cont-mean	1466	1468	12
I-cv-cont-mean	1468	1469	.
I-cv-cont-mean	1469	1471	97
O	1471	1472	,
O	1473	1475	SE
O	1476	1477	=
B-cv-cont-sd	1478	1479	0
I-cv-cont-sd	1479	1480	.
I-cv-cont-sd	1480	1482	99
O	1482	1483	)
O	1483	1484	,
O	1485	1486	p
O	1487	1488	=
O	1489	1490	.
O	1490	1493	030
O	1493	1494	.

O	1495	1499	With
O	1500	1510	covariates
O	1510	1511	,
O	1512	1515	the
O	1516	1521	group
O	1522	1532	difference
O	1533	1541	remained
O	1542	1553	significant
O	1553	1554	,
O	1555	1556	p
O	1557	1558	=
O	1559	1560	.
O	1560	1563	012
O	1563	1564	.

O	1565	1570	Women
O	1571	1574	who
O	1575	1583	received
O	1584	1588	CBSM
O	1589	1600	postsurgery
O	1601	1604	for
O	1605	1608	BCa
O	1609	1617	reported
O	1618	1623	fewer
O	1624	1634	depressive
O	1635	1643	symptoms
O	1644	1648	than
O	1649	1654	those
O	1655	1657	in
O	1658	1661	the
O	1662	1669	control
O	1670	1675	group
O	1676	1678	in
O	1679	1683	this
O	1684	1685	5
O	1685	1686	-
O	1686	1690	year
O	1691	1697	follow
O	1697	1698	-
O	1698	1700	up
O	1700	1701	.

O	1702	1714	Psychosocial
O	1715	1728	interventions
O	1729	1734	early
O	1735	1737	in
O	1738	1747	treatment
O	1748	1751	may
O	1752	1761	influence
O	1762	1766	long
O	1766	1767	-
O	1767	1771	term
O	1772	1785	psychological
O	1786	1790	well
O	1790	1791	-
O	1791	1796	being
O	1797	1799	in
O	1800	1803	BCa
O	1804	1813	survivors
O	1813	1814	.
